Share on Facebook
Share on Twitter
Share on LinkedIn

Corporations have a responsibility to their customers and the public to be ethical, honest, and forthright.

But that obligation is heightened to a degree for pharmaceutical firms, especially the ones whose customers are dealing with serious illness or acute, chronic pain.

Insys Therapeutics deals with both types of patients.

The Arizona-based drug company got approval five years ago from the U.S. Food and Drug Administration (FDA) to sell Subsys, an under-the-tongue spray for cancer patients dealing with chronic pain.

Read More